Detalhe da pesquisa
1.
Toward a hepatitis C virus vaccine: the structural basis of hepatitis C virus neutralization by AP33, a broadly neutralizing antibody.
J Virol
; 86(23): 12923-32, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22993159
2.
Comprehensive linker-scanning mutagenesis of the hepatitis C virus E1 and E2 envelope glycoproteins reveals new structure-function relationships.
J Gen Virol
; 92(Pt 10): 2249-2261, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21697343
3.
Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies.
J Virol
; 84(11): 5494-507, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20237087
4.
Development of a structural epitope mimic: an idiotypic approach to HCV vaccine design.
NPJ Vaccines
; 6(1): 7, 2021 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33420102
5.
Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein.
J Gen Virol
; 91(Pt 1): 122-32, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19793905
6.
Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.
Hepatology
; 48(6): 1779-90, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18828153
7.
Cloning, expression, and functional analysis of patient-derived hepatitis C virus glycoproteins.
Methods Mol Biol
; 379: 177-97, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17502679
8.
Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, Brazil.
PLoS Negl Trop Dis
; 10(10): e0005048, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27706161
9.
Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry.
Protein Cell
; 1(7): 664-74, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21203938
10.
CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells.
J Gen Virol
; 90(Pt 1): 48-58, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19088272
11.
Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein.
J Gen Virol
; 89(Pt 3): 653-659, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18272755
12.
Immunogenic and functional organization of hepatitis C virus (HCV) glycoprotein E2 on infectious HCV virions.
J Virol
; 81(2): 1043-7, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17079294
13.
Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33.
J Gen Virol
; 88(Pt 11): 2991-3001, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17947521
14.
Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding.
J Virol
; 80(17): 8695-704, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16912317
15.
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33.
Hepatology
; 43(3): 592-601, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16496330
16.
Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, Brazil
Artigo
em Inglês
| Arca: Repositório institucional da Fiocruz | ID: arc-18841